Bayer Says “Not Now” For Division Split Or Sell Off
At the company’s March 5 financial news conference, Bayer CEO Bill Anderson outlined the company’s four priorities for the next two to three years:
- building a strong Pharmaceuticals pipeline
- addressing litigation
- reducing debt
- continuing to implement its radical new operating model, Dynamic Shared Ownership (DSO), to improve performance
“We are a high-impact, mission-driven, life-science company with three strong businesses, but we have four challenges that urgently must be addressed,” said Anderson.
Click Here to read more.